Literature DB >> 4043055

Clinical significance of Streptococcus milleri.

P Van der Auwera.   

Abstract

The clinical features of infection in patients from whom Streptococcus milleri was isolated were analysed in an attempt to determine the clinical significance of this organism. During a four-year period Streptococcus milleri was isolated from 232 hospitalized patients. In 44 patients Streptococcus milleri was isolated in pure culture, in 45 patients together with obligate anaerobes, and in 143 patients together with aerobes with or without anaerobes. The 82 patients in whom isolation of Streptococcus milleri was considered significant had the following infections: bacteremia (8 patients), brain abscess (2), pleural empyema (9), lung abscess (1), maxillary sinusitis (7), intra-abdominal abscess (53), infection of pacemaker (1) and infection of vascular graft (1). The 150 patients in whom isolation of Streptococcus milleri was considered of questionable significance had the following: upper respiratory tract infection (12 patients), lower respiratory tract infection (6), acute cholecystitis (8), soft tissue abscess, cellulitis and surgical wound infections (83), bone and joint infections (14), genital infection (25) and miscellaneous infections (2). The overall incidence of infection with Streptococcus milleri was five cases per 1000 admissions. The study showed that Streptococcus milleri is of clinical significance not only in suppurative infections, as previously reported, but also in acute maxillary sinusitis and infection of implant material.

Entities:  

Mesh:

Year:  1985        PMID: 4043055     DOI: 10.1007/bf02148688

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  14 in total

1.  Physiological classification of oral viridans streptococci.

Authors:  J M Hardie; G H Bowden
Journal:  J Dent Res       Date:  1976-01       Impact factor: 6.116

2.  Occurrence and cultural features of Streptococcus milleri in various body sites.

Authors:  P M Poole; G Wilson
Journal:  J Clin Pathol       Date:  1979-08       Impact factor: 3.411

3.  Ecology of 350 isolates of group F Streptococcus.

Authors:  R M Bannatyne; C Randall
Journal:  Am J Clin Pathol       Date:  1977-02       Impact factor: 2.493

4.  Pneumoarthropathy in septic arthritis caused by Streptococcus milleri.

Authors:  A M Lever; T Owen; J Forsey
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-03

5.  Infections caused by group F streptococci.

Authors:  J Righter; J Zwerver
Journal:  Can Med Assoc J       Date:  1981-11-01       Impact factor: 8.262

6.  Streptococci and aerococci associated with systemic infection in man.

Authors:  M T Parker; L C Ball
Journal:  J Med Microbiol       Date:  1976-08       Impact factor: 2.472

7.  The cultural and biochemical characters of Streptococcus milleri strains isolated from human sources.

Authors:  L C Ball; M T Parker
Journal:  J Hyg (Lond)       Date:  1979-02

8.  Distribution and incidence of viridans streptococcal species in routine clinical specimens.

Authors:  K L Ruoff; J A Fishman; S B Calderwood; L J Kunz
Journal:  Am J Clin Pathol       Date:  1983-12       Impact factor: 2.493

9.  Streptococcus milleri and surgical sepsis.

Authors:  J C Tresadern; R J Farrand; M H Irving
Journal:  Ann R Coll Surg Engl       Date:  1983-03       Impact factor: 1.891

10.  Physiological differentiation of viridans streptococci.

Authors:  R R Facklam
Journal:  J Clin Microbiol       Date:  1977-02       Impact factor: 5.948

View more
  22 in total

1.  Macrorestriction fingerprinting of "Streptococcus milleri" group bacteria by pulsed-field gel electrophoresis.

Authors:  K L Bartie; M J Wilson; D W Williams; M A Lewis
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

Review 2.  Streptococcus milleri group: renewed interest in an elusive pathogen.

Authors:  S C Piscitelli; J Shwed; P Schreckenberger; L H Danziger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

3.  Splenic abscess and multiple brain abscesses caused by Streptococcus intermedius in a young healthy man.

Authors:  Jepsin Maliyil; William Caire; Rajasree Nair; Debbie Bridges
Journal:  Proc (Bayl Univ Med Cent)       Date:  2011-07

4.  Intermedilysin, a novel cytotoxin specific for human cells secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess.

Authors:  H Nagamune; C Ohnishi; A Katsuura; K Fushitani; R A Whiley; A Tsuji; Y Matsuda
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

5.  Polymicrobial septicaemia and Clostridium difficile.

Authors:  P N Levett
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-09       Impact factor: 3.267

6.  Septic Streptococcus milleri prepatellar bursitis.

Authors:  E Meys; L Michaux; M Lambert; R Triki; C Nagant de Deuxchaisnes
Journal:  Clin Rheumatol       Date:  1992-03       Impact factor: 2.980

7.  Human Fc(gamma) receptors for differentiation in throat cultures of group C "Streptococcus equisimilis" and group C "Streptococcus milleri".

Authors:  L Lebrun; M Guibert; P Wallet; M M de Maneville; J Pillot
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

8.  Presumptive identification of "Streptococcus milleri" in 5 h.

Authors:  K L Ruoff; M J Ferraro
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

9.  A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients.

Authors:  Christopher D Sibley; Michael D Parkins; Harvey R Rabin; Kangmin Duan; Jens C Norgaard; Michael G Surette
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

10.  Concentrations of ticarcillin and clavulanic acid in human bone after prophylactic administration of 5.2 g of timentin.

Authors:  D Adam; H D Heilmann; K Weismeier
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.